ArticleFrontiers in immunology2017

Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF.

Andrea J Manrique-Rincón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.